As of May 29, 2025, Omega Diagnostics Group PLC (ODX.L) reports a EV/EBITDA of 0.07.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Omega Diagnostics Group PLC's EV/EBITDA to Peers
To better understand Omega Diagnostics Group PLC's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Omega Diagnostics Group PLC (ODX.L) | 0.07 |
| Private Rented Sector SA (PFM.WA) | 310.64 |
| Xvivo Perfusion AB (XVIVO.ST) | 63.57 |
| Bactiguard Holding AB (BACTI B.ST) | 46.50 |
| Ypsomed Holding AG (YPSN.SW) | 33.56 |
| Gentian Diagnostics ASA (GENT.OL) | 32.40 |
Compared to its competitors, Omega Diagnostics Group PLC's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.